GRIFFIN MEMORIAL HOSPITAL
1. Target Overview & Investment Thesis
GRIFFIN MEMORIAL HOSPITAL is a 120-bed safety-net/medicaid heavy in CLEVELAND, OK with $7.2M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 3.8% Medicare, 57.5% Medicaid, and 38.7% commercial.
Thesis: Undervalued. Our ML models identify $538K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -350.0% (+749bps).
| Net Revenue HCRIS | $7.2M |
| Current EBITDA COMPUTED | $-25.7M |
| Operating Margin COMPUTED | -100.0% |
| Occupancy HCRIS | 86.7% |
| Revenue / Bed COMPUTED | $60K |
| Net-to-Gross HCRIS | 29.1% |
| Distress Probability ML | 53.6% |
2. Market Context & Competitive Position
OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -100.0% places it below the state median. Among 36 size-comparable peers (60-240 beds), the median margin is -2.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (60-240), prioritizing same-state peers. 36 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GRIFFIN MEMORIAL HOSPITAL (Target) | OK | 120 | $7.2M | -100.0% |
| OKLAHOMA HEART HOSPITAL | OK | 97 | $342.0M | -2.8% |
| COMANCHE COUNTY MEMORIAL HOSPI | OK | 201 | $304.2M | -7.9% |
| INTEGRIS SOUTHWEST MEDICAL CEN | OK | 169 | $267.6M | -13.5% |
| HILLCREST HOSPITAL SOUTH | OK | 152 | $218.9M | 4.9% |
| SAINT FRANCIS HOSPITAL SOUTH | OK | 104 | $198.3M | 34.4% |
| SAINT FRANCIS HOSPITAL MUSKOGE | OK | 236 | $196.5M | 11.6% |
| MCBRIDE CLINIC ORTHOPEDIC HOSP | OK | 68 | $166.9M | -5.0% |
| MERCY HOSPITAL ARDMORE | OK | 140 | $158.8M | -1.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $538K (749bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $151K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $146K | +204bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $144K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $87K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +13bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-25.7M |
| + RCM Uplift | +$538K |
| Pro Forma EBITDA | $-25.1M |
| Current Margin | -100.0% |
| Pro Forma Margin | -350.0% |
| WC Released (1x) | $275K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-39.5M | $-163.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-39.5M | $-193.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-35.5M | $-204.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-35.5M | $-233.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-43.4M | $-153.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-43.4M | $-183.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (57.5%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 53.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 36 hospitals with 60-240 beds
- Same-state prioritization (n=37)
- Comp margins: P25=-11.7% / P50=-2.6% / P75=10.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.